In cervical cancer systems with decentralized laboratory diagnostics, a significant reduction in the number of cytologic tests performed in HPV-based screening strategy, as well as potential replacing cytologic triage by p16/Ki67 dual-staining in a required pathologist evaluation, may result in the lower quality of cytological interpretation due to the decreasing number of experienced cytotechnicians. The gene discussed is MKI67; the disease is cervical cancer.